According to filings with the U.S. Securities and Exchange Commission, Oculogica is raising up to $17,952,926.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Rosina Samadani played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Oculogica
The EyeBOX is as powerful as it is easy to use. In under 4 minutes, Oculogicas proprietary technology collects and analyzes over 100,000 data points across 67-domains of eye movement to generate an objective assessment of concussion that is unique to each patient. Detailed, real-time information on TBI and concussion facilitates rapid and precise diagnosis and improved patient outcomes. The EyeBOX requires no baseline data nor individual calibration, and therefore results cannot be influenced by patient will.

To learn more about Oculogica, visit http://www.oculogica.com/

Contact:
Rosina Samadani, Chief Executive Officer
484-393-2694
https://www.linkedin.com/in/rsamadani/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.